To describe the implementation phase of a robot-assisted radical cystectomy (RARC) programme including side-effect profiles and impact on length of stay (LOS).
Introduction
Radical cystectomy (RC) with pelvic lymph node dissection and urinary diversion is the standard of care for muscleinvasive bladder carcinoma (MIBC) and an increasing proportion of patients with high-risk non-MIBC. Despite improvements in perioperative care, there remains a substantial morbidity associated with RC, published series report overall complication rates of 58-67%, and higher-grade complication (Clavien-Dindo III-IV) rates of 13-24% [1, 2] . In addition, national Health Episode Statistics data (HES) in England have highlighted significant differences between individual surgical units in both re-admission rates and overall length of stay (LOS) [3] .
Use of minimally invasive surgery (MIS) has been shown to result in lower blood loss and reduced morbidity, with evidence of improved convalescence [4, 5] . A systematic review demonstrated that patients undergoing robot-assisted RC (RARC) have decreased perioperative complications, less estimated blood loss, lower transfusion rates, greater lymph node yields, and a reduced LOS [2, [5] [6] [7] [8] [9] [10] [11] [12] . Furthermore, RARC has been shown to have comparable oncological outcomes to those achieved with an open surgical approach [8] [9] [10] 13, 14] .
In recent years, there has been a rapid adoption of robotassisted surgery (RAS) by urological surgeons; although to date this has predominantly been in the context of robotassisted radical prostatectomy. However, with increasing experience in RAS, an emerging trend has been observed in experienced robotic centres to extend the use of RAS into RC programmes. National registry data in England for 2014 (BAUS Complex Operations Dataset) recorded that 15% of patients undergoing RC underwent a RARC in the 12-month period implying that, although adoption of the technique is infantile, expertise is clearly spreading.
The present series describes the implementation phase of RARC within a designated regional cancer centre with the intention of highlighting patient suitability, operating duration, side-effect profile, compatibility with enhanced recovery methodology, and impact on LOS.
Patients and Methods
Between April 2013 and December 2015, 114 consecutive patients underwent RARC. In this series, all cases were commenced using RAS. Exclusion criteria within our unit include inability to place the patient in steep Trendelenburg (e.g., severe peripheral vascular disease, cranial pathology or refractory glaucoma). Obesity, higher-stage tumours, impaired anaerobic threshold, or prior surgery, are not routine exclusions. Surgery was performed by one of two consultant surgeons (J.S.M. or E.W.) in a designated urological cancer centre. Both surgeons were already experienced in RAS having previously established a service for robot-assisted laparoscopic radical prostatectomy (RALP). Each surgeon performed~100 RAS procedures per annum.
Patient demographics are shown in Table 1 and indications  for RARC in Table 2 . Neoadjuvant chemotherapy was administered in all eligible patients with MIBC.
Operative Technique
A six-port transperitoneal approach was used utilising the DaVinci Si â robotic system (Intuitive Surgical, CA, USA). The procedural steps included initial mobilisation and division of both ureters followed by an extended pelvic lymphadenectomy. The lymph node template was defined proximally by the crossing of the ureter on the common iliac artery and included the internal iliac chain, as well as external iliac and obturator nodes. Haemostasis was achieved using a combination of Weck Hem-o-Lok clips (Teleflex, NC, USA) and a haemostatic energy device (LigaSure, Coviden, MN, USA). Concurrent hysterectomy and bilateral salpingooophorectomy with preservation of the vagina was performed in female patients, and prostatectomy was performed in male patients. The specimen was placed in a retrieval bag and removed via the vaginal vault in women or through a minilaparotomy midline incision in men. Patients underwent formation of either an ileal conduit or a neobladder, with extracorporeal reconstruction in the early phase of implementation but subsequently intracorporeal approach in the latter stages. In intracorporeal reconstruction, all bowel anastomoses were made using a stapler device (Endo GIA TM , Covidien, MN, USA) brought in through a 15-mm left lateral port. The robotic port was inserted through this 15-mm port at all other times to allow use of the fourth arm.
A stented 'Wallace' or 'Bricker' uretero-ileal anastomosis was made and implanted into the ileal segment of a modified Studer pouch in the case of orthotopic neobladders. In patients undergoing neobladder reconstruction, the stents were placed in the neobladder and attached to the urethral catheter by a non-absorbable suture. No surgical drains were used consistent with our previously described ERAS programme for open RC (ORC). A dedicated surgical care practitioner with extensive experience in patient-side assistance during RAS was used for most cases. The retrieval port site was closed with nonabsorbable braided suture (Nurolon â ; Ethicon US, Johnson & Johnson, CA, USA) continuous suture.
Urethrectomy was not performed routinely at the time of the RARC but rather discussed as a second-staged procedure in patients considered high-risk for urethral recurrence. The rationale for this approach is to limit operating time and morbidity during the primary surgery, and also to offer patient choice in terms of urethral surveillance or urethrectomy. In sexually active patients, urethral preservation is considered important for longer term recovery of erectile function. 
Anaesthetic Considerations
A dedicated anaesthetic team was established at implementation of the robotic programme, with universal adoption of a standardised anaesthetic protocol specifically tailored for RARC (Fig. 1) . Standardisation is the key not only to enable delivery of what we think is best care but also to be able to evaluate changes / quality improvements in the care delivered.
Standard premedication included a proton-pump inhibitor, anti-emetic, and slow-release opiate. Multi-modal analgesia and minimisation of opiate requirements was applied for all cases. Patients were anaesthetised in the anaesthetic room but positioned awake on the operating table to ensure comfortable positioning and avoidance of pressure points. Both arms were wrapped in 'gels' and placed by the patient's side. Shoulder restraints were not used, as the patients do not slide when laid on full-length gels. A throat-pack was placed in all cases and patients' eyelids were taped closed after application of protective eye drops. Careful positioning and docking of the robotic console was standardised using a dedicated theatre team; all docking was performed in the midline with the patient in lithotomy and 24-26°T rendelenburg. This was reduced to a maximum of 10-12°f or reconstruction but in some cases the patient could be leveled off to 0°. Care was taken to ensure that the lateral robotic arms could move freely without directly contacting the patient's lower limbs. Postoperative stay in the theatre recovery area is extended to 1.5 h to negate the need for admission to the intensive therapy unit (ITU). Joint review by the consultant anaesthetist and consultant surgeon preceded discharge to the ward.
Special Considerations
In patients with prior laparotomies, the umbilical incision was still used for initial access if the laparotomy scar did not extend to or beyond the umbilicus. In cases where the midline scar incorporated the umbilicus, a lateral port was placed initially using the Hassan cut-down technique. If necessary, adhesiolysis was performed by conventional laparoscopy in order to allow placement of the remaining ports. Within our unit, conversion to ORC at this stage would be on account of being unable to gain robotic access. In our experience, this is relatively uncommon.
Obesity was not a contraindication to RARC. Care needs to be taken, as the patient is more likely to move position during the application of steep Trendelenburg. Ventilation pressures can also increase and periods of increased pneumoperitoneum pressure are to be avoided. Airway pressures were tolerated to 40 cmH 2 O but preferably nearer to 35 cmH 2 O. Carbon dioxide levels were transiently tolerated to 6 kPa but ideally <5 kPa. Our philosophy with RC in the obese is that a difficult procedure robotically is likely to be even more difficult to perform with open surgery due to the restrictions of surgical access, limited vision, and venous oozing.
Exeter Enhanced Recovery Programme (ERP) for RARC
The key care elements of the Exeter ERP have been reported previously [15] . The ERP aims to standardise all aspects of pre-, peri-and postoperative care to enable the patient to have a faster return to normal function and earlier discharge from hospital ( Fig. 1 ).
All patients considered for RARC are discussed at the institutional multi-disciplinary team meeting. All patients eligible for radical treatment are considered for neoadjuvant chemotherapy as standard. All patients were assessed in the pelvic oncology outpatient clinic by E.W. or J.S.M. and counselled by a Cancer Nurse Specialist. Fitness for surgery was assessed and patient education regarding the ERP was undertaken by senior nurse practitioners. Selected high-risk patients were referred for cardio-pulmonary exercise testing (CPET) and functional assessment by a consultant anaesthetist where appropriate. High-risk criteria included patients with extensive cardiac or respiratory co-morbidity or those with poor functional status. CPET was not used as a 'rule-out' test but rather to guide the level of dependency of the postoperative care setting using the previously described parameters for anaerobic threshold [16] . Unless deemed highrisk, patients were planned for return to a normal ward setting rather than high-dependency care.
Patients were admitted on the day of surgery with carbohydrate loading up to 2 h preoperatively. Bowel preparation was not administered and drains were not routinely placed. Postoperative nasogastric tubes were not used unless the patient subsequently developed an ileus. Early feeding and mobilisation were encouraged from the outset. Ward review was provided daily by the on-call consultant urological surgeon who performed ward rounds throughout a consecutive 7-day period to allow continuity of surgical care.
Discharge Criteria
Patients were discharged from hospital once they had fulfilled the following criteria: pain adequately controlled by oral analgesia, oral intake resumed, bowels opened, and patients independently mobile and competent with stoma or neobladder care. All patients were routinely contacted by telephone following discharge by a clinical nurse specialist as part of the ERP (Fig. 1) .
Patients who underwent construction of an ileal conduit attended a preoperative outpatient appointment with the stoma care team, during which they were provided with written information and dummy appliances. Patients also have the option of being introduced to a buddy patient for further support. They are seen again by the stoma care team on the day of surgery, at which time the siting is checked. Ward-based education is given by both the stoma care team, and as an extended role of ward nurses. Stents are removed at 5-7 days unless the patient is undergoing a salvage RC in which case they are left in situ for 14 days.
Patients with an orthotopic neobladder were seen preoperatively by the bladder and bowel care team, and also by the stoma care team. They were offered the opportunity of meeting a buddy patient. Intermittent self-catheterisation is not routinely taught preoperatively, but it is discussed. They receive regular follow-up from a bladder care nurse and return after 21 days for a cystogram. If this is satisfactory, the catheter and stents (which are tied to the catheter) are removed on the same day.
There is no difference in stoma or neobladder care between patients undergoing an extracorporeal or intracorporeal procedure.
Data Analysis
No ethical approval was required as this was a service evaluation of patients undergoing RARC and audit and refinement of care elements is a key component of enhanced recovery after surgery (ERAS). Data were collected prospectively on the national cystectomy registry (BAUS Complex Operation Dataset). This is a mandated national registry for urological surgeons undertaking complex urological cancer surgery in the UK. Re-admission to hospital was screened for retrospectively from the BAUS dataset and patient electronic records. All data were recorded on a Microsoft Excel spreadsheet for descriptive analysis.
Results

Operative Results and Post-operative Care
The procedural time, lymph node yield, and the rate of conversion to an open procedure is given in Table 3 . One patient required conversion to ORC due to tumour size and was also deemed inoperable once converted to an open procedure. Table 4 , shows the level of dependency of postoperative ward care and the rate of unplanned admission to ITU.
Complications and Re-admissions
Postoperative complications are summarised in Tables 5, 6 and 7. The overall complication rate was 53.5% with highergrade complications (Clavien-Dindo grade III-IV) seen in 21 patients (18.4%). There did not seem to be a significant difference in overall complication rates between patients undergoing extracorporeal (eRARC) or intracorporeal (iRARC) urinary diversion (Tables 6 and 7) . However, the rate of radiologically guided drain insertion was higher with iRARC, and the rates of wound dehiscence and unplanned ITU/ critical care unit (CCU) admissions were higher with eRARC (Tables 6 and 7 ). There were no in-patient mortalities and the overall 30-day mortality rate was 0.9% (one patient: cerebral haemorrhage at 2 weeks postoperatively). The 90-day mortality rate was 2.6%. Six patients required return to theatre during their initial admission. Two patients were readmitted with late wound dehiscence, which was surgically repaired and one patient was re-admitted with a caecal volvulus requiring laparotomy. The overall ITU admission rate was 15.8% (18 patients). In all, 21 patients (18.3%) were readmitted to our institution within 30 days of surgery, 17.28% in the eRARC group and 21.21% in the iRARC group. Figure 2 shows the impact of the addition of RARC to our previously established ERP for ORC [15] . Table 8 shows that Table 3 Operative results of patients undergoing RARC in the Exeter ERP.
LOS
Variable Value
Total procedural time, h 3-5 Estimated blood loss, mL 300-500 Patients requiring transfusion, n (%) 10 (8.8) Mean lymph node yield (n = 95), n 16.0 Conversion to ORC, n 1 more than half of patients were discharged home during postoperative days 5-7; with 75% of patients having a LOS of ≤10 days. LOS for patients undergoing ileal conduit urinary diversion was slightly lower than for those undergoing neobladder reconstruction.
Discussion
The present study describes the incorporation of RAS for RC into an existing ERP. The addition of MIS has conferred a modest improvement to the LOS in our institution. Higher major complication and re-admission rates were noted in the RARC series, compared to ORC. The 30-day mortality rate has shown a modest improvement compared with our previously published ORC series, and is consistent with other major published RC series [17] .
LOS has shown a modest improvement during the introduction of RARC. This is likely, in part, to be due to experience gained from implementing RALP in our centre. This meant that the theatre staff were already familiar with the robot, and therefore technical difficulties from introducing a new piece of technology have been minimised. Both surgeons were already experienced robotic surgeons, and therefore some of the learning curve had already been climbed. In addition, ward nursing staff were experienced in caring for patients who had undergone a robot-assisted laparoscopic procedure.
Regular departmental morbidity and mortality meetings were conducted throughout the period of this study. Identification and discussion of complications may also have brought benefits to LOS in the adoption of RARC.
Over the later part of the study period, intracorporeal urinary diversion techniques have been introduced. It is likely that this represents a second learning curve, and is thought to be one factor contributing to the lack of a significant improvement in LOS compared to ORC. LOS was highest in those patients who had intracorporeal formation of a neobladder, and was generally higher for a neobladder compared to an ileal conduit. Patients who are offered a neobladder are generally fit and well-motivated, and these patients have the opportunity to enter a 'buddy' programme preoperatively, to link with a patient who already has a neobladder. This prepares them well for caring for their neobladder and theoretically shortens LOS. However, the highest rate of Clavien-Dindo III-IV complications was seen in the group of patients who underwent intracorporeal neobladder formation, and this may account for the higher LOS.
Once intracorporeal diversion techniques have been fully adopted the LOS will be re-examined to assess whether further improvements have been made in the period following the implementation phase. It is proposed that LOS will improve due to reduced analgesia requirements and physiological stress due to the avoidance of a laparotomy wound. Furthermore, we expect that any effects of the early learning curve will reduce over time. Although we have shown only a modest improvement in LOS, 86.8% of patients from our present cohort had a LOS of <15 days. This is on a background of a LOS, which is already considerably lower than the national LOS of 15 days.
MIS results in decreased physiological stress and minimal bowel handling, although the authors accept that intracorporeal techniques could have a negative impact on this due to a longer duration of pneumoperitoneum and the need to handle bowel with robotic instruments. Previous studies have shown reduced blood loss, transfusion requirements, and LOS for RARC [2, 5, 8, 18] .
Patients therefore have a better physiological state postoperatively, and most can be admitted directly back to ward-level care. All patients who were admitted back to a ward were sent to a dedicated urology ward, with experienced nursing staff who are familiar with departmental protocols. Preoperative screening as part of case selection, allows for appropriate elective admission to ITU if required. The rate of admission to ITU in our institution has already been shown to be low [15] and has remained low. There was a higher rate of unplanned ITU/CCU admission in the group who underwent eRARC. However, this may reflect the small numbers in each group. In our centre, all high-dependency care is provided in a level 3 intensive care unit as there is no intermediate facility such as a high dependency unit. A proportion of those admitted to ITU in the present series could have been managed in a surgical high-dependency unit, if facilities were available. It is notable that all admissions were due to unforeseen complications rather than a failure of preoperative planning in terms of predicting the dependency of postoperative care. Overall, there were 10 unplanned ITU admissions over 33 months, which represents the equivalent of one admission every 3 months, which is in keeping with an acceptable level for a high-volume centre and a manageable workload for the higher dependency facilities.
Using an ERP alongside MIS allows for standardisation of care pre-, intra-, and postoperatively. Patients are cared for by a standardised team, consisting of a limited number of anaesthetists, surgical care practitioners, and surgeons. This approach allows nurses and junior doctors providing wardbased care to manage patients appropriately, and simplifies identification of patients who are deviating from the expected postoperative course, promoting earlier identification and treatment of complications.
The rate of major complications (Clavien-Dindo III-IV) has increased compared to the ORC series. This may to be due to the learning curve associated with the adoption of a new operative technique. The incidence of major complications was highest in patients who underwent intracorporeal formation of a neobladder; however, the numbers in each group are too small to subject to statistical evaluation. Six patients returned to theatre. Of these, three patients had a wound dehiscence, and a further two patients were readmitted with a wound dehiscence that required surgical management. The rate of wound dehiscence was higher in the eRARC group, Adoption of intracorporeal urinary diversion as the preferred surgical technique, could be expected to reduce this rate, as only a mini-laparotomy would be required in men for removal of the surgical specimen.
Five patients underwent radiologically guided drainage of a collection, with most of these patients having undergone iRARC. It is conceivable that this is a technical aspect related to the learning curve of intracorporeal reconstruction. Meticulous attention is particularly paid to ensuring a watertight ileo-ureteric anastomosis and avoiding tension on the bowel segment. As radiological services have expanded in recent years, this may represent a reduction in the number of patients who otherwise would have required a surgical approach to manage a pelvic/abdominal collection. Further refinement of operative, anaesthetic and ERPs in the future may improve this.
In all, 21 (18.3%) patients were re-admitted to our centre within 30 days. Of those patients re-admitted, 42.9% (nine patients) had a minor, Clavien-Dindo II, complication.
It is not clear how many people visited their GP or local hospital for advice regarding an uncertainty over their postoperative care. Some minor complications could be safely managed at home with appropriate support (e.g. serous fluid leak from a port site) and improvements in patient and GP education may facilitate this.
Mortality rates have remained low following the introduction of RARC. It appears that a combination of MIS and ERP in a high-volume centre has contributed.
If a reduction in LOS can be proven with the introduction of RARC, cost-savings may be made from this element of patient stay, which may offset the initial costs associated with setting-up a robotic service.
Limitations
The data collection used for the present study is limited in that it was retrospective and largely from the BAUS registry, and therefore relied upon correct data being uploaded. Where data were uploaded and split into categories, e.g. estimated blood loss, some detail is lost. Complications and readmissions were further analysed using electronic records; however, we are unable to account for patients who were readmitted to their referring hospital. Our unit is a tertiary referral centre for a large geographical area, and patients may be more likely to visit their local hospital following a complication compared to centres who cover a smaller area, although with increasing centralisation of services, this may become an increasingly common issue. The data are from a The data presented comprised descriptive statistics, as the numbers are too small to apply statistical analysis.
When analysing complications, patients were classified by the highest grade of complication they experienced, and therefore the absolute number of lower-grade classifications is not presented.
Conclusions
We have shown that the introduction of RARC does not adversely affect LOS. Enhanced recovery principles can safely be applied to all patients undergoing RARC, and most patients do not need admission to an intensive care or highdependency unit postoperatively.
The effect of introducing RARC and ERP may become relevant within the debate surrounding the commissioning of RARC and increasing centralisation of cancer services.
Further areas of interest include the effect of adopting intracorporeal diversion techniques on LOS. Future studies could also include an element of patient feedback to establish the length of time taken to return to normal activity, as this has not been directly addressed in the present study, in addition to assessing continence and potency rates.
